ScoreWhy is Emmessar Biotech & Nutrition Ltd ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-35.56%
EBIT Growth (5y)
-154.93%
EBIT to Interest (avg)
-0.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0.34
Tax Ratio
46.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
-58.72%
ROE (avg)
17.56%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
37
Price to Book Value
1.55
EV to EBIT
-3.62
EV to EBITDA
-3.90
EV to Capital Employed
5.11
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-135.00%
ROE (Latest)
4.12%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
PAT(9M)
Higher at Rs 0.40 Cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Emmessar Biotech
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.40 Cr
than preceding 12 month period ended Dec 2025 of Rs 0.32 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
